Kwan A. Chan

Sar, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 12 publications

Nasopharyngeal Cancer Screening: Methods, Target Populations, and Next Steps.

Nasopharyngeal Cancer Screening: Methods, Target Populations, and Next Steps.

Journal: Otolaryngologic clinics of North America

Published: September 23, 2025

Integrative analysis reveals associations between oral microbiota dysbiosis and host genetic and epigenetic aberrations in oral cavity squamous cell carcinoma.

Integrative analysis reveals associations between oral microbiota dysbiosis and host genetic and epigenetic aberrations in oral cavity squamous cell carcinoma.

Journal: NPJ biofilms and microbiomes

Published: April 09, 2023

Combining Transoral Nasopharyngeal Brush and Plasma Epstein-Barr Virus DNA in Detecting Locally Recurrent Nasopharyngeal Carcinoma.

Combining Transoral Nasopharyngeal Brush and Plasma Epstein-Barr Virus DNA in Detecting Locally Recurrent Nasopharyngeal Carcinoma.

Journal: Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery

Published: December 31, 2022

Nasopharyngeal carcinoma: an evolving paradigm.

Nasopharyngeal carcinoma: an evolving paradigm.

Journal: Nature reviews. Clinical oncology

Published: May 18, 2021

The Intersection between Oral Microbiota, Host Gene Methylation and Patient Outcomes in Head and Neck Squamous Cell Carcinoma.

The Intersection between Oral Microbiota, Host Gene Methylation and Patient Outcomes in Head and Neck Squamous Cell Carcinoma.

Journal: Cancers

Published: October 14, 2020

Droplet digital PCR of tumor suppressor gene methylation in serial oral rinses of patients with head and neck squamous cell carcinoma.

Droplet digital PCR of tumor suppressor gene methylation in serial oral rinses of patients with head and neck squamous cell carcinoma.

Journal: Head & neck

Published: September 12, 2020

Plasma Epstein-Barr virus DNA as an archetypal circulating tumour DNA marker.

Plasma Epstein-Barr virus DNA as an archetypal circulating tumour DNA marker.

Journal: The Journal of pathology

Published: December 06, 2018

Plasma DNA for early cancer detection - opportunities and challenges.

Plasma DNA for early cancer detection - opportunities and challenges.

Journal: Expert review of molecular diagnostics

Published: December 05, 2018

FetalQuantSD: accurate quantification of fetal DNA fraction by shallow-depth sequencing of maternal plasma DNA.

FetalQuantSD: accurate quantification of fetal DNA fraction by shallow-depth sequencing of maternal plasma DNA.

Journal: NPJ genomic medicine

Published: December 01, 2015

Noninvasive prenatal molecular karyotyping from maternal plasma.

Noninvasive prenatal molecular karyotyping from maternal plasma.

Journal: PloS one

Published: January 03, 2013

Technical concerns about immunoprecipitation of methylated fetal DNA for noninvasive trisomy 21 diagnosis.

Technical concerns about immunoprecipitation of methylated fetal DNA for noninvasive trisomy 21 diagnosis.

Journal: Nature medicine

Published: September 11, 2012

Noninvasive fetal trisomy 21 detection using chromosome-selective sequencing: a variation of the molecular counting theme.

Noninvasive fetal trisomy 21 detection using chromosome-selective sequencing: a variation of the molecular counting theme.

Journal: Expert review of molecular diagnostics

Published: May 24, 2012

Showing 1-12 of 12

Last Updated: 09/26/2026